↓ Skip to main content

Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis

Overview of attention for article published in Clinical and Molecular Hepatology, March 2012
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
Published in
Clinical and Molecular Hepatology, March 2012
DOI 10.3350/kjhep.2012.18.1.32
Pubmed ID
Authors

Hyun Young Woo, Jun Mo Youn, Si Hyun Bae, Jeong Won Jang, Jung Hoon Cha, Hye Lim Kim, Ho Jong Chun, Byung Gil Choi, Jong Young Choi, Seoung Kew Yoon

Abstract

Low-dose metronomic chemotherapy involves the frequent administration of comparatively low doses of cytotoxic agents with no extended breaks, and it may be as efficient as and less toxic than the conventional maximum tolerated dose therapy. This study evaluated the feasibility and therapeutic efficacy of metronomic chemotherapy in patients with advanced hepatocellular carcinoma (HCC) with major portal vein thrombosis (PVT).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 20%
Student > Ph. D. Student 2 13%
Student > Bachelor 2 13%
Student > Doctoral Student 1 7%
Professor 1 7%
Other 5 33%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 6 40%
Agricultural and Biological Sciences 3 20%
Biochemistry, Genetics and Molecular Biology 2 13%
Unspecified 1 7%
Unknown 3 20%